The Government’s Plan to Turn Kodak Into a Pharmaceutical Company Sure Seems Underdeveloped
First, although solid public stats on global API production are not available, the data we have do not indicate that government funding is urgently needed:
[A]ccording to the Food and Drug Administration, of the roughly 2,000 global manufacturing facilities that produce active pharmaceutical ingredients (APIs), 13 percent are in China; 28 percent are in the USA, 26 percent in the EU, and 18 percent in India. For the APIs of World Health Organization “essential medicines” on the U.S. market, 21 percent of manufacturing facilities are located in the United States, 15 percent in China; and the rest in the EU, India, and Canada.
